Abstract
Despite decades of research and advancements in diagnostics and treatment, tuberculosis remains a major public health concern, particularly in low- and middle-income countries. New bioinformatics and computational methods are needed to interrogate the intersection of host- and bacterial genomes and identify novel targets for anti-tuberculosis drugs. Host genotype datum and paired infecting bacterial isolate information were analysed for associations using a multinomial logistic regression framework implemented in SNPTest. Two geographically distinct cohorts were evaluated: a cohort of 947 participants self-identifying as belonging to a five-way admixed South African population and a Ghanaian cohort consisting of 3 311 participants. We report potential associations between host genetic variants and multiple members of the Mycobacterium tuberculosis complex (MTBC). Although none of the variants analyzed in the South African cohort passed the GWAS cut-off for significance, 32 single nucleotide polymorphisms were identified in the Ghanaian cohort as being statistically significantly associated with risk for infection with strains of different members of the MTBC. Further analysis revealed that two of these SNPs were directly genotyped, and the rest were imputed using the 1000 Genomes Phase 3 reference panel. The availability of paired host-pathogen data is imperative for investigating strain-specific interactions between MTBC and its host. As demonstrated by this study, the implementation of a multinomial logistic regression using paired host-pathogen data may prove valuable for further research investigating the complex relationships driving infectious disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was partially funded by the South African government through the South African Medical Research Council. This work was also supported by the National Research Foundation of South Africa (grant number 93460) to E.H. and by a Strategic Health Innovation Partnership grant from the South African Medical Research Council and Department of Science and Innovation/South African Tuberculosis Bioinformatics Initiative to G.T. The content is solely the responsibility of the authors and does not necessarily represent the official views of the South African Medical Research Council.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
1)Health Research Ethics Committee of Stellenbosch University 2)Committee on Human Research, Publications and Ethics, School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana 3)Ethics Committee of the Ghana Health Service, Accra, Ghana
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Tables added
Data Availability
Summary statistics for the South African cohorts data can be made available to researchers who meet the criteria for access to confidential data after application to the Health Research Ethics Committee of Stellenbosch University. Requests may be sent to: Prof Craig Kinnear, E mail: gkin{at}sun.ac.za
